Brad Rees

Hostworks Group Pty Ltd. operates as an online digital media solutions company. It offers critical business systems, online ecommerce, and online media services. The company was founded by Marty John Gauvin and Rainer Rhedey on April 14, 1983 and is headquartered in Adelaide, Australia.

Part of GroPrep Ltd., Biotech Australia develops medicines and technologies used for targeting specific diseases. Biotech Australia was acquired by GroPrep Ltd. on February 27, 2002.

The Fox Chase Cancer Center owns and operates hospitals. It is an independent, non-profit institution that is engaged in cancer treatment, research and prevention services. The firm's staff provides consultations and treatment recommendations for different types of adult cancer. The company was founded in 1904 and is headquartered in Philadelphia, PA.

Riverland Capital Ltd. operates as a private equity and venture capital firm specializing in fund of fund investments. It seeks to invest in healthcare, education, media, services, and advanced manufacturing industry. The company was founded by Andrew Adamovich in 2005 and is headquartered in Hong Kong.

Yuanyu Advertising (China) Co. Ltd. provides radio advertising services. The firm also provides marketing and advertising services in Chongqing, Jinan, Yantai, Taiyuan, Chengdu and Changsha. The company was founded in 2002 and is headquartered in Shanghai, China.

The Garvan Institute of Medical Research engages in the provision of biomedical research. It focuses in cancer, genomics and epigenetics, immunity and inflammation, healthy ageing, clinical trials, and research centres. The company was founded in 1963 and is headquartered in Darlinghurst, Australia.

Advancell Isotopes Pty Ltd is a radiopharmaceutical company located in Australia. The Australian company is focused on developing a pipeline of targeted alpha therapies to improve clinical outcomes in cancer patients. Advancell's proprietary platform technology, a novel alpha isotope generator, addresses the greatest unmet need in targeted alpha therapy - the reliable and scalable supply of isotope. The company's drug discovery, preclinical processes, and state-of-the-art facilities leverage daily access to 212pb, the ideal isotope for targeted alpha therapy.